Trademarkia Logo

Canada

C$
TOZYRE
REGISTERED

on 3 Nov 2020

Last Applicant/ Owned by

SK BIOPHARMACEUTICALS CO. LTD.

221, Pangyoyeok-ro, Bundang-gu, Seongnam-siGyeonggi-do

KR

Serial Number

1911468 filed on 25th Jul 2018

Registration Number

TMA1086930 registered on 3rd Nov 2020

Registration expiry Date

3rd Nov 2030

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

TOZYRE

Trademark usage description

medicines for human and veterinary preparations for the treatment of cancer and central nervous system diseases namely, central nervous system infecti Read More

Classification Information


Class [005]
Medicines for human and veterinary preparations for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); biological preparations for medical purposes namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); biochemical preparations for medical purposes namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); chemicals for pharmaceutical use namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); medical preparations of trace elements for human and animal use namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); ferments for use as pharmaceutical preparations for general health and well being; biotechnological preparations for medical purposes namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); chemical preparations for medicinal purposes namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); chemical preparations for medical or veterinary purposes namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); chemical preparations for sanitary use for preventing pathogenic infections in humans and animals; immunomodulators; vitamin preparations; vaccines for bacterial, fungal, viral and parasitic infections; dietary supplements for general health and well being; therapeutic drugs and agents namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); chemico-pharmaceutical preparations namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS); bacteriological preparations for medical and veterinary use namely for the treatment of cancer and central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, catalepsy, seizures, locked-in syndrome, meningitis, myelopathy, Huntington's disease, centrally acting muscle spasm, neurodegenerative disorders namely, Alzheimer's disease, Parkinson's disease, cognitive impairment, neurodegeneration, psychiatric disorder namely, mania, schizophrenia, anxiety, bipolar disorder, depression, post-traumatic stress disorder (PTSD), smoking, sleep disorders namely, narcolepsy, cataplexy, pain disorders namely, neuropathic pain, migraines, fibromyalgia, trigeminal neuralgia, diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, visceral pain, inflammatory pain, inherited erythromelalgia (IEM), paroxysmal extreme pain disorder, endocrine and metabolic diseases namely, diabetes, hypoglycemia, hypoglycemia unawareness (ha), steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, dyslipidemia, hypolipidemia, galactosemia, phenylketonuria, metabolic syndrome (syndrome x), gout, hyperthyroidism, hypothyroidism, nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), obesity, movement disorders namely, Tourette's syndrome, muscular dystrophy, essential tremor, multiple sclerosis, itching, myotonia, Fragile X syndrome (FXS), Rett syndrome, Angelman syndrome, cardiovascular disease, angina, osteoarthritis, anemia, restrictive lung disease, amyotrophic lateral sclerosis (ALS)


Classification kind code

11

Mark Details


Serial Number

1911468

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 130
on 6th Apr 2020
Note to file
Submitted for opposition 27
on 19th Feb 2020
Approval Notice Sent
Submitted for opposition 26
on 19th Feb 2020
Approved
Submitted for opposition 15
on 25th Jun 2019
Correspondence Created
Submitted for opposition 15
on 5th Apr 2019
Correspondence Created
Submitted for opposition 22
on 5th Sept 2018
Search Recorded
Submitted for opposition 20
on 5th Sept 2018
Examiner's First Report
Submitted for opposition 31
on 1st Aug 2018
Formalized
Submitted for opposition 1
on 26th Jul 2018
Created
Submitted for opposition 30
on 25th Jul 2018
Filed